1910

BusinessWire · Jan 2026

Announces PEGASUS™, a multimodal AI model for engineering cell-permeable macrocyclic peptides and highlights the first reported permeable peptides with more than two polar or ionizable fragments.

BusinessWire · Nov 2025

Publishes CANDID-CNS™, which predicts BBB penetration for bRo5 molecules and incorporates stereochemistry; the company says it outperforms Pfizer's CNS MPO benchmarks on several tasks.

1910.ai press release · Oct 2024

Accenture Ventures invested in 1910 and joined advisory boards; the partnership expands commercialization of the ITO platform for biopharma R&D.

Inc. · Mar 2024

Profile of Jen Asher and 1910's mission, growth, and Microsoft partnership; includes context on the company's Boston Seaport footprint and founding story.

1910.ai press release · Feb 2024

Announces a five-year commercial agreement with Microsoft to combine 1910's data and lab automation with Azure Quantum Elements for drug discovery.